Close

News

Russia Expects To Register Second COVID-19 Vaccine EpiVacCorona By Oct 15

Russia expects to register another COVID-19 vaccine candidate by mid-October, according to Russian consumer safety watchdog Rospotrebnadzor. Russia expects to register another COVID-19 vaccine candidate by mid-October, according to Russian consumer safety watchdog Rospotrebnadzor. The vaccine candidate “EpiVacCorona”, which completed...

Samsung Biologics and AstraZeneca forge strategic manufacturing partnership for global supply

Samsung Biologics and AstraZeneca announced a long-term supply agreement, valued at approximately $330.8 million. Under this agreement, Samsung Biologics will provide large-scale commercial manufacturing for drug substance in its Plant 3 as well as drug product to support AstraZeneca’s...

Biocair: Transporting Temperature-Sensitive COVID-19 Vaccines

We all hope that a COVID-19 vaccine is on the horizon - but the global cold chain must be prepared to distribute these vaccines around the world. This is an unprecedented task, with a large number of transfer points across...

Turkish Cargo builds up a global air bridge for special cargo shipments

Carrying 1 of each 20 air cargo carried around the world, Turkish Cargo increased its global market share to 5.4 percent from 3.9 percent by accomplishing a growth by 67 percent within the first half of 2020 thanks to...

Glyconics awarded internationally recognised quality certification forthe development of its range of diagnostic medical devices

Innovative diagnostics company, Glyconics® has been awarded an internationally recognised quality certification for the design and development of its medical devices product range. Following a review by BSI, one of the world’s leading notified bodies, Glyconics has been awarded ISO...

Major Pharma Companies, Including Novartis And Merck, Build Federated Learning Platform For Drug Discovery

Amgen, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, GSK, Institut De Recherches Servier, Janssen, Merck, and Novartis — inked an agreement to build a shared platform called MELLODDY (Machine Learning Ledger Orchestration for Drug Discovery). In partnership with Nvidia, Owkin, and...

Nippon Express adds blockchain to global pharma supply networks

Nippon Express (NE) is in the process of developing pharmaceutical supply chain networks. NE says it will look to employ the digital technologies of IoT and blockchain to track logistics information end-to-end. This will seek to optimise supply chains for...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read